PathoFinder Develops and Provides Next Generation Multiplex PCR Diagnostics for Infectious Diseases
PathoFinder is a privately owned molecular diagnostics company founded in 2004. The company focuses on the development and commercialization of a new generation of molecular diagnostics, with special emphasis on infectious diseases. Proprietary MultiFinder® and SmartFinder® technologies enable the detection and differentiation of up to 22 viral and bacterial pathogens in a single assay